MapLight officer plans $855K common share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
MapLight Therapeutics, Inc. (MPLT) officer Kris Hanson reported an intended sale of 27,834 common shares through Jefferies LLC, with an aggregate market value of $854,503.80 and an approximate sale date of May 4, 2026. The notice says the planned sales are pursuant to a previously adopted 10b5-1 selling plan.
The notice also lists two sales in the prior three months: 1,529 shares for gross proceeds of $40,974.77 on April 15, 2026, and 298 shares for gross proceeds of $8,156.77 on April 16, 2026.
Key Figures
Key Terms
10b5-1 Selling plan regulatory
Vested RSU financial
Aggregate Market Value financial
Gross Proceeds financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.